We use cookies to improve your experience on our Website. We need cookies to continuously improve the services, to enable certain features and when embedding services or content of third parties, such as video player. By using our website, you agree to the use of cookies. We use different types of cookies. You can personalize your cookie settings here:

Show detail settings
Please find more information in our privacy statement.

There you may also change your settings later.

News

DGE Congress: Translational Research for a Future without Diabetes

In Germany, some six million people suffer from diabetes, and in addition around 270,000 new cases of the disease are reported each year. The German Center for Diabetes Research (DZD) conducts research on the causes, prevention and treatment of this metabolic disorder. From March 15 - 17, the 60th German Congress for Endocrinology will take place in Würzburg. There in numerous symposia, DZD scientists will discuss how research results can rapidly be translated into patient care.

 

At the 60th German Congress for Endocrinology, DZD scientists will present their research areas and current results. “The DZD places particular focus on the timely transfer of results from the laboratory to patient care,” said Professor Martin Hrabě de Angelis, speaker and member of the DZD Executive Board, “because new approaches to prevent and treat diabetes and its secondary diseases are urgently needed.”

In his lecture “Novel Pharmacotherapies for Obesity” Professor Matthias Tschöp, director of the Institute for Diabetes and Obesity (IDO) of Helmholtz Zentrum München, will report about new therapeutic approaches for the personalized prevention and treatment of diabetes and obesity. Professor Matthias Blüher, DZD researcher from the Faculty of Medicine of the University of Leipzig, will illuminate the “Chances and Risks of Pharmacotherapy Approaches” in the treatment of obesity.
To investigate the development of diabetes and new therapies, the mouse is a successful model. With the German Diabetes Mouse Clinic, the DZD has an outstanding research facility. Together with his DZD colleague Tschöp, Hrabě de Angelis, director of the Institute of Experimental Genetics at Helmholtz Zentrum München and professor at Technische Universität München, will give a lecture at the DGE Congress on "Mouse Models for Diabetes Mellitus and Obesity".
“Diabetes and Bones” is the topic of the lecture by DZD expert Professor Andreas Pfeiffer of Charité Universitätsmedizin Berlin and the German Institute of Human Nutrition (DIfE). In the advanced training program for physicians Professor Michael Roden, member of the DZD Executive Board and scientific director of the German Diabetes Center, will give a lecture on “What’s New in Diabetes Drug Therapy – What’s Important for the Primary Care Physician to Know?”

"What is special about research at the DZD is the close interdisciplinary collaboration of the scientists of diverse disciplines with different research focuses," said Professor Matthias M. Weber, media spokesman of the German Society of Endocrinology (DGE). This leads to innovative research approaches such as the epigenetic inheritance of a metabolic disorder due to malnutrition or a faulty diet or also the development of new therapies. "Only when we succeed in rapidly transferring research results into practice will we be equipped to react to the challenges of the 'diabetes wave' and to provide our patients with optimal treatment,” said Weber.

Further information about the congress and the program can be found on the Internet at www.dge2017.de

Endocrinology is the study of hormones, metabolism and diseases in this field. Hormones are secreted from the endocrine glands – for example the thyroid gland or the pituitary gland, but also from certain cells in the testes and ovaries, (endo = inside the organism), i.e. into the blood. By contrast, "exocrine" glands such as salivary or sweat glands release their secretions to the "outside".